218 related articles for article (PubMed ID: 11437403)
1. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract][Full Text] [Related]
2. APC truncation and increased beta-catenin levels in a human breast cancer cell line.
Schlosshauer PW; Brown SA; Eisinger K; Yan Q; Guglielminetti ER; Parsons R; Ellenson LH; Kitajewski J
Carcinogenesis; 2000 Jul; 21(7):1453-6. PubMed ID: 10874025
[TBL] [Abstract][Full Text] [Related]
3. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
4. APC mutations are infrequent but present in human lung cancer.
Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO
Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829
[TBL] [Abstract][Full Text] [Related]
5. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Sparks AB; Morin PJ; Vogelstein B; Kinzler KW
Cancer Res; 1998 Mar; 58(6):1130-4. PubMed ID: 9515795
[TBL] [Abstract][Full Text] [Related]
7. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
8. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
9. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
10. Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Tsutsumi M; Sasaki Y; Murata N; Konishi Y
Cancer Res; 2000 Dec; 60(23):6611-6. PubMed ID: 11118043
[TBL] [Abstract][Full Text] [Related]
11. Analysis of beta-catenin gene mutations in pancreatic tumors.
Gerdes B; Ramaswamy A; Simon B; Pietsch T; Bastian D; Kersting M; Moll R; Bartsch D
Digestion; 1999; 60(6):544-8. PubMed ID: 10545724
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
13. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
Furlong MT; Morin PJ
Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
[TBL] [Abstract][Full Text] [Related]
14. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
15. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
16. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
17. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
18. Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas.
Miyake N; Maeta H; Horie S; Kitamura Y; Nanba E; Kobayashi K; Terada T
Pathol Int; 2001 Sep; 51(9):680-5. PubMed ID: 11696170
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin mutation in carcinoma of the uterine endometrium.
Fukuchi T; Sakamoto M; Tsuda H; Maruyama K; Nozawa S; Hirohashi S
Cancer Res; 1998 Aug; 58(16):3526-8. PubMed ID: 9721853
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
